This website uses cookies to improve performance and your user experience on our website. If you do not agree with the use of cookies other than the essential ones, you can manage your preferences by clicking on "Cookie Settings"

PT

Back

Portuguese PTO and courts refuse Merck SCP

Ricardo J. Alves Silva and Inês Rodrigues report on the Portuguese INPI and IP Court decisions which refused the Supplementary Certificate of Protection for the medicinal product Mavenclad® having cladribine as an active ingredient, based on the European Patent 2 805 723 (EP'723). Lexology - International Law Office

Published on Lexology

27/11/2023

Back

Portuguese PTO and courts refuse Merck SCP

Ricardo J. Alves Silva and Inês Rodrigues report on the Portuguese INPI and IP Court decisions which refused the Supplementary Certificate of Protection for the medicinal product Mavenclad® having cladribine as an active ingredient, based on the European Patent 2 805 723 (EP'723). Lexology - International Law Office

Published on Lexology

27/11/2023